What is the Average Dose of Mounjaro?

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro, follows a structured dose escalation protocol designed to minimize side effects while building therapeutic benefit. Most patients start at 2.5 milligrams per week and advance incrementally every four weeks, though individual factors significantly influence the timeline and target dose. PlexusDx compounded tirzepatide injections deliver this same mechanism through licensed 503A pharmacies, with pricing that remains flat regardless of your dose progression.

Tirzepatide Starting Dose and Initial Titration Schedule

The standard tirzepatide starting dose is 2.5 milligrams administered as a subcutaneous injection once weekly. This modest opening dose allows your digestive system and metabolic pathways to acclimate to dual GLP-1 and GIP receptor activation without overwhelming nausea or appetite suppression. Most patients experience mild appetite reduction and gradual weight loss even at this entry level.

From week one through week four, you remain on 2.5 mg weekly injections while your body establishes tolerability. Your healthcare provider monitors your response during this period—measuring appetite changes, energy levels, gastrointestinal symptoms, and early weight trends. If you tolerate the initial dose well, the protocol typically advances to 5 mg at week five.

Progressive Dose Escalation Over 16 Weeks

The tirzepatide dose ladder advances in 2.5 mg increments at four-week intervals: 2.5 mg (weeks 1–4), 5 mg (weeks 5–8), 7.5 mg (weeks 9–12), and 10 mg (weeks 13–16). Each step targets deeper receptor engagement and stronger metabolic signaling. Some patients reach a therapeutic plateau at 7.5 mg, while others continue progressing to 10 mg or even 12.5 mg for maximal glycemic and weight-loss outcomes.

Dose increases are not automatic—they depend on your reported tolerability, side-effect profile, and weight-loss velocity. If you experience significant nausea, vomiting, or appetite suppression at week eight, your provider may delay advancement or hold your dose at 5 mg for an additional four-week cycle. This individualized approach prevents unnecessary discomfort and supports long-term medication adherence.

How Body Composition and Genetic Factors Influence Your Tirzepatide Dose

Higher body weight, insulin resistance severity, and metabolic history all shape optimal tirzepatide dosing. Patients with polycystic ovary syndrome (PCOS), type 2 diabetes, or pronounced central adiposity often require higher maintenance doses to achieve durable weight reduction compared to those with isolated weight gain. Age, kidney function, and prior medication responses further refine dosing recommendations.

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Maintenance Dose and Long-Term Tirzepatide Therapy

Once your dose reaches an effective level—commonly 7.5 mg or 10 mg weekly—you continue that same injection every seven days indefinitely, or until your provider recommends discontinuation. The maintenance phase typically spans months to years, with periodic weight and metabolic reassessments every three to six months. Many patients maintain steady weight loss for 12–24 months on a fixed dose before plateau occurs.

PlexusDx compounded tirzepatide injections remain priced at a flat $289/mo (or $249/mo on the 6-month plan) regardless of whether you are injecting 2.5 mg or 15 mg weekly. Your dose may need to go up over time—your price won't. This transparent, commitment-based pricing model removes financial barriers to dose optimization and ensures you can advance your therapy without surprise cost increases. All formulations ship from licensed 503A compounding pharmacies serving all 50 states without insurance requirements.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical tirzepatide dose patients reach?

Most patients reach a maintenance dose of 7.5 mg to 10 mg weekly within 12–16 weeks. Some achieve therapeutic benefit at lower doses (5 mg), while others progress to 12.5 or 15 mg for maximal effect. Your individual response determines your optimal dose—not a fixed protocol.

Can you skip tirzepatide dose increases if you feel fine?

Yes, dose escalation is flexible. If you are losing weight and tolerating your current dose well, your provider may recommend staying at that level indefinitely rather than advancing. Progressive dose titration benefits patients with insufficient early weight loss or stable plateaus, but not everyone needs to reach the highest available dose.

How does PlexusDx pricing work if my dose increases?

PlexusDx tirzepatide injections cost a flat $289/mo (or $249/mo on the 6-month plan) across all tiers, regardless of your dose level. Whether you inject 2.5 mg or 15 mg weekly, your monthly cost remains the same. No dose-based surcharges, no insurance required, and HSA/FSA eligible.

What happens if tirzepatide causes severe nausea at your starting dose?

Nausea typically peaks in the first one to two weeks at each dose level and gradually improves over days. If severe nausea persists, your provider may recommend staying at your current dose for an extra four weeks, reducing food portions, or taking injections with light meals. Rarely, dose reduction or medication discontinuation becomes necessary.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The PlexusDx Precision Peptide Genetic Test examines variants in GLP-1R, GIPR, and metabolic genes (FTO, MC4R) to reveal how efficiently your body responds to tirzepatide signaling. Patients with favorable receptor variants may achieve robust weight loss at lower doses, while others may require higher doses to unlock the same benefit. This $99 add-on test informs personalized dosing strategy and accelerates your path to optimal therapy.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.